GANDOLFI, LETIZIA
GANDOLFI, LETIZIA
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE (attivo dal 28/10/2011 al 31/12/2022)
Second primary malignancy in myelofibrosis patients treated with ruxolitinib
2021 Polverelli N.; Elli E.M.; Abruzzese E.; Palumbo G.A.; Benevolo G.; Tiribelli M.; Bonifacio M.; Tieghi A.; Caocci G.; D'Adda M.; Bergamaschi M.; Binotto G.; Heidel F.H.; Cavazzini F.; Crugnola M.; Pugliese N.; Bosi C.; Isidori A.; Bartoletti D.; Auteri G.; Latagliata R.; Gandolfi L.; Martino B.; Scaffidi L.; Cattaneo D.; D'Amore F.; Trawinska M.M.; Stella R.; Markovic U.; Catani L.; Pane F.; Cuneo A.; Krampera M.; Semenzato G.; Lemoli R.M.; Vianelli N.; Breccia M.; Russo D.; Cavo M.; Iurlo A.; Palandri F.
Efficacy and safety of biosimilar epoetin alpha in patients with chronic lymphoid neoplasms and chemotherapy-induced anaemia: An observational, retrospective, monocentric analysis
2018 Broccoli, Alessandro; Argnani, Lisa; Stefoni, Vittorio; Gandolfi, Letizia; Zinzani, Pier Luigi
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years
2016 Casadei, Beatrice; Pellegrini, Cinzia; Pulsoni, Alessandro; Annechini, Giorgia; De Renzo, Amalia; Stefoni, Vittorio; Broccoli, Alessandro; Gandolfi, Letizia; Quirini, Federica; Tonialini, Lorenzo; Morigi, Alice; Argnani, Lisa; Zinzani, Pier Luigi
Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study
2016 Federico, Massimo; Luminari, Stefano; Pellegrini, Cinzia; Merli, Francesco; Pesce, Emanuela Anna; Chauvie, Stephane; Gandolfi, Letizia; Capodanno, Isabella; Salati, Massimiliano; Argnani, Lisa; Zinzani, Pier Luigi
Leukocytoclastic vasculitis associated with hairy cell leukemia at diagnosis: A case report and review of the literature
2016 Broccoli, Alessandro; Gandolfi, Letizia; Pellegrini, Cinzia; Agostinelli, Claudio; Argnani, Lisa; Zinzani, PIER LUIGI
Long-term responders after Brentuximab vedotin: Single-center experience on relapsed and refractory hodgkin lymphoma and anaplastic large cell lymphoma patients
2016 Gandolfi, Letizia; Pellegrini, Cinzia; Casadei, Beatrice; Stefoni, Vittorio; Broccoli, Alessandro; Tonialini, Lorenzo; Morigi, Alice; Argnani, Lisa; Zinzani, PIER LUIGI
Short-course R-CHOP followed by (90)Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results
2016 Stefoni, Vittorio; Casadei, Beatrice; Bottelli, C; Gaidano, G; Ciochetto, C; Cabras, M. G; Ansuinelli, M; Argnani, Lisa; Broccoli, Alessandro; Gandolfi, Letizia; Pellegrini, Cinzia; Zinzani, PIER LUIGI
Vemurafenib mucosal side-effect.
2016 A. Pileri;M. Cricca;L. Gandolfi;C. Misciali;B. Casadei;P. L. Zinzani;A. Patrizi
Fludarabine-Mitoxantrone-Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patients
2015 Zinzani, P. L.; Pellegrini, C.; Broccoli, A.; Gandolfi, L.; Stefoni, V.; Casadei, B.; Maglie, R.; Argnani, L.; Pileri S, S.
High efficacy of the MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis, a 20 year experience
2015 Derenzini, Enrico; Stefoni, Vittorio; Pellegrini, Cinzia; Gandolfi, Letizia; Broccoli, Alessandro; Casadei, Beatrice; Quirini, Federica; Argnani, Lisa; Tonialini, Lorenzo; Zinzani, Pier Luigi
Multisystemic and Multiresistant Langerhans Cell Histiocytosis: A Case Treated With BRAF Inhibitor
2015 Gandolfi, Letizia; Adamo, Sarah; Pileri, Alessandro; Broccoli, Alessandro; Argnani, Lisa; Zinzani, Pier Luigi
The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: experience on 74 patients
2015 P. L. Zinzani;A. Broccoli;B. Casadei;V. Stefoni;C. Pellegrini;L. Gandolfi;R. Maglie;L. Argnani;S. Pileri;S. Fanti
Is it really possible to cure hairy cell leukemia patients only with frontline therapy?
2014 Zinzani PL, Stefoni V, Broccoli A, Pellegrini C, Gandolfi L, Casadei B, Maglie R, Pileri S, Argnani L.
Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphoma.
2014 Pellegrini Cinzia, Argnani Lisa, Broccoli Alessandro, Stefoni Vittorio, Derenzini Enrico, Gandolfi Letizia, Casadei Beatrice, Maglie Roberto, Pileri Stefano, Zinzani Pier Luigi.
Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remission in advanced follicular lymphoma.
2014 Derenzini E, Casadei B, Broccoli A, Gandolfi L, Pellegrini C, Zinzani PL.
Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients
2013 Broccoli A;Stanzani M;Bandini G;Bonifazi F;Stefoni V;Pellegrini C;Derenzini E;Gandolfi L;Quirini F;Argnani L;Tschon M;Casadei B;Baccarani M;Zinzani PL
Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study
2013 Zinzani P.L.;Pellegrini C.;Merla E.;Ballerini F.;Fabbri A.; Guarini A.;Pavone V.;Quintini G.;Puccini B.;Vigliotti M.L.; Stefoni V.; Derenzini E.;Broccoli A.;Gandolfi L.;Quirini F.;Casadei B.;Argnani L.;Baccarani M.
Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens.
2013 Zinzani PL; Pellegrini C; Gandolfi L; Casadei B; Derenzini E; Broccoli A; Quirini F; Argnani L; Pileri S; Celli M; Fanti S; Poletti V; Stefoni V; Baccarani M.
Primary ocular adnexal lymphomas: a retrospective study of 25 patients.
2013 Gandolfi L;Stefani G;Narducci R;Argnani L;Polito E;Zinzani PL
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma.
2012 Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; Pellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M.
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
Second primary malignancy in myelofibrosis patients treated with ruxolitinib | Polverelli N.; Elli E.M.; Abruzzese E.; Palumbo G.A.; Benevolo G.; Tiribelli M.; Bonifacio M.; Ti...eghi A.; Caocci G.; D'Adda M.; Bergamaschi M.; Binotto G.; Heidel F.H.; Cavazzini F.; Crugnola M.; Pugliese N.; Bosi C.; Isidori A.; Bartoletti D.; Auteri G.; Latagliata R.; Gandolfi L.; Martino B.; Scaffidi L.; Cattaneo D.; D'Amore F.; Trawinska M.M.; Stella R.; Markovic U.; Catani L.; Pane F.; Cuneo A.; Krampera M.; Semenzato G.; Lemoli R.M.; Vianelli N.; Breccia M.; Russo D.; Cavo M.; Iurlo A.; Palandri F. | 2021-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
Efficacy and safety of biosimilar epoetin alpha in patients with chronic lymphoid neoplasms and chemotherapy-induced anaemia: An observational, retrospective, monocentric analysis | Broccoli, Alessandro; Argnani, Lisa; Stefoni, Vittorio; Gandolfi, Letizia; Zinzani, Pier Luigi | 2018-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years | Casadei, Beatrice; Pellegrini, Cinzia; Pulsoni, Alessandro; Annechini, Giorgia; De Renzo, Amalia;... Stefoni, Vittorio; Broccoli, Alessandro; Gandolfi, Letizia; Quirini, Federica; Tonialini, Lorenzo; Morigi, Alice; Argnani, Lisa; Zinzani, Pier Luigi | 2016-01-01 | CANCER MEDICINE | - | 1.01 Articolo in rivista | cam4.684.pdf |
Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study | Federico, Massimo; Luminari, Stefano; Pellegrini, Cinzia; Merli, Francesco; Pesce, Emanuela Anna;... Chauvie, Stephane; Gandolfi, Letizia; Capodanno, Isabella; Salati, Massimiliano; Argnani, Lisa; Zinzani, Pier Luigi | 2016-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | e139.full.pdf |
Leukocytoclastic vasculitis associated with hairy cell leukemia at diagnosis: A case report and review of the literature | Broccoli, Alessandro; Gandolfi, Letizia; Pellegrini, Cinzia; Agostinelli, Claudio; Argnani, Lisa;... Zinzani, PIER LUIGI | 2016-01-01 | TUMORI | - | 1.01 Articolo in rivista | - |
Long-term responders after Brentuximab vedotin: Single-center experience on relapsed and refractory hodgkin lymphoma and anaplastic large cell lymphoma patients | Gandolfi, Letizia; Pellegrini, Cinzia; Casadei, Beatrice; Stefoni, Vittorio; Broccoli, Alessandro...; Tonialini, Lorenzo; Morigi, Alice; Argnani, Lisa; Zinzani, PIER LUIGI | 2016-01-01 | THE ONCOLOGIST | - | 1.01 Articolo in rivista | - |
Short-course R-CHOP followed by (90)Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results | Stefoni, Vittorio; Casadei, Beatrice; Bottelli, C; Gaidano, G; Ciochetto, C; Cabras, M. G; Ansuin...elli, M; Argnani, Lisa; Broccoli, Alessandro; Gandolfi, Letizia; Pellegrini, Cinzia; Zinzani, PIER LUIGI | 2016-01-01 | BLOOD CANCER JOURNAL | - | 1.01 Articolo in rivista | bcj201629.pdf |
Vemurafenib mucosal side-effect. | A. Pileri;M. Cricca;L. Gandolfi;C. Misciali;B. Casadei;P. L. Zinzani;A. Patrizi | 2016-01-01 | JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | - | 1.01 Articolo in rivista | - |
Fludarabine-Mitoxantrone-Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patients | Zinzani, P. L.; Pellegrini, C.; Broccoli, A.; Gandolfi, L.; Stefoni, V.; Casadei, B.; Maglie, R.;... Argnani, L.; Pileri S, S. | 2015-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
High efficacy of the MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis, a 20 year experience | Derenzini, Enrico; Stefoni, Vittorio; Pellegrini, Cinzia; Gandolfi, Letizia; Broccoli, Alessandro...; Casadei, Beatrice; Quirini, Federica; Argnani, Lisa; Tonialini, Lorenzo; Zinzani, Pier Luigi | 2015-01-01 | BMC CANCER | - | 1.01 Articolo in rivista | 12885_2015_Article_1903.pdf |
Multisystemic and Multiresistant Langerhans Cell Histiocytosis: A Case Treated With BRAF Inhibitor | Gandolfi, Letizia; Adamo, Sarah; Pileri, Alessandro; Broccoli, Alessandro; Argnani, Lisa; Zinzani..., Pier Luigi | 2015-01-01 | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | - | 1.01 Articolo in rivista | - |
The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: experience on 74 patients | P. L. Zinzani;A. Broccoli;B. Casadei;V. Stefoni;C. Pellegrini;L. Gandolfi;R. Maglie;L. Argnani;S.... Pileri;S. Fanti | 2015-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
Is it really possible to cure hairy cell leukemia patients only with frontline therapy? | Zinzani PL, Stefoni V, Broccoli A, Pellegrini C, Gandolfi L, Casadei B, Maglie R, Pileri S, Argna...ni L. | 2014-01-01 | ANNALS OF HEMATOLOGY | - | 1.01 Articolo in rivista | - |
Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphoma. | Pellegrini Cinzia, Argnani Lisa, Broccoli Alessandro, Stefoni Vittorio, Derenzini Enrico, Gandolf...i Letizia, Casadei Beatrice, Maglie Roberto, Pileri Stefano, Zinzani Pier Luigi. | 2014-01-01 | THE ONCOLOGIST | - | 1.01 Articolo in rivista | - |
Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remission in advanced follicular lymphoma. | Derenzini E, Casadei B, Broccoli A, Gandolfi L, Pellegrini C, Zinzani PL. | 2014-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients | Broccoli A;Stanzani M;Bandini G;Bonifazi F;Stefoni V;Pellegrini C;Derenzini E;Gandolfi L;Quirini ...F;Argnani L;Tschon M;Casadei B;Baccarani M;Zinzani PL | 2013-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study | Zinzani P.L.;Pellegrini C.;Merla E.;Ballerini F.;Fabbri A.; Guarini A.;Pavone V.;Quintini G.;Pucc...ini B.;Vigliotti M.L.; Stefoni V.; Derenzini E.;Broccoli A.;Gandolfi L.;Quirini F.;Casadei B.;Argnani L.;Baccarani M. | 2013-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens. | Zinzani PL; Pellegrini C; Gandolfi L; Casadei B; Derenzini E; Broccoli A; Quirini F; Argnani L; P...ileri S; Celli M; Fanti S; Poletti V; Stefoni V; Baccarani M. | 2013-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
Primary ocular adnexal lymphomas: a retrospective study of 25 patients. | Gandolfi L;Stefani G;Narducci R;Argnani L;Polito E;Zinzani PL | 2013-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma. | Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; P...ellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M. | 2012-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |